| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.6 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |